President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for bankruptcy. There’s never a dull ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Model and body activist Tess Holliday clapped back at a critic who told her to take Ozempic for weight loss and they wouldn’t ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

The FDA is warning patients about “counterfeit” Ozempic. Drug manufacturer Novo Nordisk seized “several hundred units” from ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...